Regeneron Pharmaceuticals, Inc. SEC filings REGN

Regeneron Pharmaceuticals, Inc. has 1,000 filings in SEC EDGAR's recent list, going back to Sep 13, 2017. Its latest annual report, Form ARS, was filed on Apr 24, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Oct 30, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Oct 30, 2026 (results of operations). The company's fiscal year ends on December 31.

Regeneron Pharmaceuticals, Inc. SEC filings
Form Description Filed Period
4 Insider transaction Nov 5, 2026 Nov 3, 2026
13F-HR Filing Nov 5, 2026 Sep 30, 2026
4 Insider transaction Nov 5, 2026 Nov 3, 2026
144 Notice of proposed sale Nov 4, 2026 —
4 Insider transaction Nov 4, 2026 Nov 2, 2026
4 Insider transaction Nov 4, 2026 Nov 2, 2026
4 Insider transaction Nov 4, 2026 Nov 2, 2026
4 Insider transaction Nov 4, 2026 Nov 2, 2026
144 Notice of proposed sale Nov 4, 2026 —
4 Insider transaction Nov 3, 2026 Oct 30, 2026
144 Notice of proposed sale Nov 3, 2026 —
4 Insider transaction Nov 3, 2026 Oct 30, 2026
4 Insider transaction Nov 3, 2026 Oct 30, 2026
144 Notice of proposed sale Nov 2, 2026 —
144 Notice of proposed sale Nov 2, 2026 —
144 Notice of proposed sale Nov 2, 2026 —
144 Notice of proposed sale Oct 30, 2026 —
144 Notice of proposed sale Oct 30, 2026 —
144 Notice of proposed sale Oct 30, 2026 —
4 Insider transaction Oct 15, 2026 Oct 13, 2026
144 Notice of proposed sale Oct 14, 2026 —
4 Insider transaction Sep 3, 2026 Sep 2, 2026
4 Insider transaction Sep 3, 2026 Sep 2, 2026
144 Notice of proposed sale Sep 3, 2026 —
144 Notice of proposed sale Sep 2, 2026 —
144 Notice of proposed sale Sep 2, 2026 —
4 Insider transaction Aug 21, 2026 Aug 19, 2026
4 Insider transaction Aug 20, 2026 Aug 18, 2026
4 Insider transaction Aug 12, 2026 Aug 10, 2026
4 Insider transaction Aug 12, 2026 Aug 10, 2026
144 Notice of proposed sale Aug 10, 2026 —
144 Notice of proposed sale Aug 10, 2026 —
13F-HR Filing Aug 7, 2026 Jun 30, 2026
4 Insider transaction Jul 7, 2026 Jul 2, 2026
144 Notice of proposed sale Jul 2, 2026 —
13F-HR Filing May 8, 2026 Mar 31, 2026
4 Insider transaction May 4, 2026 May 1, 2026
SCHEDULE 13G Ownership over 5% (passive) Apr 30, 2026 —
4 Insider transaction Apr 3, 2026 Apr 1, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Mar 27, 2026 —
4 Insider transaction Mar 3, 2026 Mar 2, 2026
4 Insider transaction Feb 23, 2026 Feb 19, 2026
144 Notice of proposed sale Feb 19, 2026 —
4 Insider transaction Feb 11, 2026 Feb 9, 2026
4 Insider transaction Feb 11, 2026 Feb 9, 2026
144 Notice of proposed sale Feb 9, 2026 —
144 Notice of proposed sale Feb 9, 2026 —
13F-HR Filing Feb 6, 2026 Dec 31, 2025
4 Insider transaction Jan 8, 2026 Jan 7, 2026
144 Notice of proposed sale Jan 7, 2026 —
4 Insider transaction Jan 6, 2026 Jan 2, 2026
4 Insider transaction Jan 6, 2026 Jan 2, 2026
4 Insider transaction Jan 6, 2026 Jan 2, 2026
4 Insider transaction Jan 6, 2026 Jan 2, 2026
4 Insider transaction Jan 6, 2026 Jan 2, 2026
4 Insider transaction Jan 6, 2026 Jan 2, 2026
4 Insider transaction Jan 6, 2026 Jan 2, 2026
4 Insider transaction Jan 6, 2026 Jan 2, 2026
4 Insider transaction Jan 6, 2026 Jan 2, 2026
4 Insider transaction Jan 6, 2026 Jan 2, 2026
4 Insider transaction Jan 6, 2026 Jan 2, 2026
4 Insider transaction Jan 5, 2026 Dec 31, 2025
4 Insider transaction Jan 5, 2026 Dec 31, 2025
4 Insider transaction Dec 31, 2025 Dec 30, 2025
4 Insider transaction Dec 11, 2025 Dec 9, 2025
4 Insider transaction Dec 11, 2025 Dec 9, 2025
4 Insider transaction Dec 11, 2025 Dec 9, 2025
4 Insider transaction Dec 11, 2025 Dec 9, 2025
4 Insider transaction Dec 11, 2025 Dec 9, 2025
4 Insider transaction Dec 9, 2025 Dec 5, 2025
4 Insider transaction Dec 9, 2025 Dec 5, 2025
4 Insider transaction Dec 9, 2025 Dec 5, 2025
4 Insider transaction Dec 9, 2025 Dec 5, 2025
4 Insider transaction Dec 9, 2025 Dec 5, 2025
4 Insider transaction Dec 9, 2025 Dec 5, 2025
4 Insider transaction Nov 24, 2025 Nov 20, 2025
4 Insider transaction Nov 24, 2025 Nov 20, 2025
144 Notice of proposed sale Nov 20, 2025 —
4 Insider transaction Nov 10, 2025 Nov 7, 2025
144 Notice of proposed sale Nov 7, 2025 —
13F-HR Filing Nov 7, 2025 Sep 30, 2025
4 Insider transaction Oct 31, 2025 Oct 29, 2025
4 Insider transaction Oct 31, 2025 Oct 29, 2025
144 Notice of proposed sale Oct 29, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 6, 2025 —
13F-HR Filing Aug 1, 2025 Jun 30, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Jun 5, 2025 —
13F-HR Filing May 2, 2025 Mar 31, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Apr 22, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 12, 2025 —
13F-HR Filing Feb 7, 2025 Dec 31, 2024
4 Insider transaction Jan 6, 2025 Jan 2, 2025
4 Insider transaction Jan 6, 2025 Jan 2, 2025
4 Insider transaction Jan 6, 2025 Jan 2, 2025
4 Insider transaction Jan 6, 2025 Jan 2, 2025
4 Insider transaction Jan 6, 2025 Jan 2, 2025
4 Insider transaction Jan 6, 2025 Jan 2, 2025
4 Insider transaction Jan 6, 2025 Jan 2, 2025
4 Insider transaction Jan 6, 2025 Jan 2, 2025
4 Insider transaction Jan 6, 2025 Jan 2, 2025
4 Insider transaction Jan 6, 2025 Jan 2, 2025
4 Insider transaction Jan 3, 2025 Dec 31, 2024
4 Insider transaction Dec 18, 2024 Dec 16, 2024
4 Insider transaction Dec 18, 2024 Dec 16, 2024
4 Insider transaction Dec 18, 2024 Dec 16, 2024
4 Insider transaction Dec 18, 2024 Dec 16, 2024
4 Insider transaction Dec 18, 2024 Dec 16, 2024
4 Insider transaction Dec 18, 2024 Dec 16, 2024
4 Insider transaction Dec 18, 2024 Dec 16, 2024
4 Insider transaction Dec 10, 2024 Dec 6, 2024
4 Insider transaction Dec 10, 2024 Dec 6, 2024
4 Insider transaction Dec 10, 2024 Dec 9, 2024
4 Insider transaction Dec 10, 2024 Dec 6, 2024
4 Insider transaction Dec 10, 2024 Dec 6, 2024
4 Insider transaction Dec 10, 2024 Dec 6, 2024
4 Insider transaction Dec 10, 2024 Dec 6, 2024
4 Insider transaction Nov 12, 2024 Nov 8, 2024
4 Insider transaction Nov 5, 2024 Nov 1, 2024
144 Notice of proposed sale Nov 1, 2024 —
4 Insider transaction Oct 3, 2024 Oct 1, 2024
4 Insider transaction Oct 3, 2024 Oct 1, 2024
144 Notice of proposed sale Oct 1, 2024 —
4 Insider transaction Sep 5, 2024 Sep 4, 2024
4 Insider transaction Sep 5, 2024 Sep 3, 2024
4 Insider transaction Sep 5, 2024 Sep 3, 2024
144 Notice of proposed sale Sep 3, 2024 —
4 Insider transaction Aug 29, 2024 Aug 28, 2024
144 Notice of proposed sale Aug 28, 2024 —
4 Insider transaction Aug 19, 2024 Aug 15, 2024
4 Insider transaction Aug 19, 2024 Aug 15, 2024
144 Notice of proposed sale Aug 15, 2024 —
4 Insider transaction Aug 15, 2024 Aug 13, 2024
144 Notice of proposed sale Aug 15, 2024 —
144 Notice of proposed sale Aug 14, 2024 —
4 Insider transaction Aug 14, 2024 Aug 13, 2024
4 Insider transaction Aug 12, 2024 Aug 8, 2024
144 Notice of proposed sale Aug 8, 2024 —
4 Insider transaction Aug 7, 2024 Aug 7, 2024
144 Notice of proposed sale Aug 7, 2024 —
4 Insider transaction Aug 6, 2024 Aug 2, 2024
4 Insider transaction Aug 5, 2024 Aug 2, 2024
4 Insider transaction Aug 5, 2024 Aug 1, 2024
4 Insider transaction Aug 5, 2024 Aug 1, 2024
4 Insider transaction Aug 5, 2024 Aug 1, 2024
144 Notice of proposed sale Aug 2, 2024 —
144 Notice of proposed sale Aug 1, 2024 —
144 Notice of proposed sale Aug 1, 2024 —
4 Insider transaction Jul 12, 2024 Jul 11, 2024
4 Insider transaction Jul 2, 2024 Jul 1, 2024
4 Insider transaction Jul 2, 2024 Jul 1, 2024
144 Notice of proposed sale Jul 1, 2024 —
4 Insider transaction Jun 25, 2024 Jun 24, 2024
4 Insider transaction Jun 25, 2024 Jun 24, 2024
144 Notice of proposed sale Jun 24, 2024 —
4 Insider transaction Jun 17, 2024 Jun 14, 2024
144 Notice of proposed sale Jun 14, 2024 —
4 Insider transaction Jun 13, 2024 Jun 11, 2024
144 Notice of proposed sale Jun 12, 2024 —
4 Insider transaction Jun 12, 2024 Jun 10, 2024
4 Insider transaction Jun 12, 2024 Jun 10, 2024
4 Insider transaction Jun 10, 2024 Jun 6, 2024
4 Insider transaction Jun 7, 2024 Jun 5, 2024
144 Notice of proposed sale Jun 6, 2024 —
4 Insider transaction Jun 5, 2024 Jun 3, 2024
4 Insider transaction Jun 5, 2024 Jun 3, 2024
144 Notice of proposed sale Jun 5, 2024 —
144 Notice of proposed sale Jun 3, 2024 —
4 Insider transaction May 29, 2024 May 28, 2024
144 Notice of proposed sale May 28, 2024 —
4 Insider transaction May 22, 2024 May 21, 2024
144 Notice of proposed sale May 21, 2024 —
4 Insider transaction May 17, 2024 May 17, 2024
4 Insider transaction May 17, 2024 May 16, 2024
4 Insider transaction May 17, 2024 May 15, 2024
4 Insider transaction May 15, 2024 May 13, 2024
144 Notice of proposed sale May 15, 2024 —
144 Notice of proposed sale May 14, 2024 —
4 Insider transaction May 6, 2024 May 3, 2024
4 Insider transaction May 3, 2024 May 1, 2024
4 Insider transaction May 3, 2024 May 1, 2024
144 Notice of proposed sale May 1, 2024 —
144 Notice of proposed sale May 1, 2024 —
4 Insider transaction May 1, 2024 Apr 29, 2024
4 Insider transaction May 1, 2024 Jan 2, 2024
4 Insider transaction Apr 3, 2024 Apr 1, 2024
4 Insider transaction Apr 3, 2024 Apr 1, 2024
144 Notice of proposed sale Apr 1, 2024 —
4 Insider transaction Mar 15, 2024 Mar 13, 2024
144 Notice of proposed sale Mar 14, 2024 —
4 Insider transaction Mar 5, 2024 Mar 1, 2024
4 Insider transaction Mar 5, 2024 Mar 1, 2024
144 Notice of proposed sale Mar 1, 2024 —
4 Insider transaction Feb 28, 2024 Feb 26, 2024
4 Insider transaction Feb 28, 2024 Feb 26, 2024
4 Insider transaction Feb 28, 2024 Feb 26, 2024
144 Notice of proposed sale Feb 26, 2024 —
4 Insider transaction Feb 26, 2024 Feb 26, 2024
4 Insider transaction Feb 26, 2024 Feb 22, 2024
144 Notice of proposed sale Feb 26, 2024 —
4 Insider transaction Feb 26, 2024 Feb 22, 2024

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
REGN (Nasdaq)
Fiscal year ends
December 31
Incorporated in
NY
Headquarters
Tarrytown, NY
SEC filer status
Large accelerated filer
SEC CIK
872589
Former names
REGENERON PHARMACEUTICALS INC (until Jun 19, 2019)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.